Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- GeoEye: Sell Alert on Satellite Troubles
- Chris Fernandez submits: Wednesday I sold my full position in GeoEye, Inc. (NASDAQ: GEOY), a provider of space-based and aerial imagery and geospatial information, at $20.75 per share. The total amount in my portfolio was was for a 3/4 position out of a full position, accounting for about...
- External links 2009-05-21
- U.S. Government Cancels BASIC Program; GeoEye to Benefit
- Chris Fernandez submits: Well, it looks like our current economic climate was good for something. The AP has reported that the U.S. government, feeling the pressure of the current economic crisis and as a result of the their need to bail out and possibly fund over $700 billion in...
- External links 2008-10-23
- Two Stocks to Consider Shorting
- Chris Fernandez submits: In the course of the last year, I have tried to keep my stock picks on this site long-only. I believe it’s time to make a change and start including short positions in the portfolio as I feel that we are missing out on significant opportunities...
- External links 2009-02-09
- Rick's to Open Nude Bar, GeoEye Helps Catch Pirates Off Kenya
- Chris Fernandez submits: I wanted to update you on 2 of the companies in the PeakStocks.com portfolio that have had developments in the last few days that you should be aware of. This includes: by Chris Fernandez
- External links 2009-01-15
Additional Resources
- Hoping AAR Will Rise Above Airline Cutbacks
- Chris Fernandez submits: It’s about that time again when earnings season is upon us with some companies reporting their earnings mid-stream. PeakStocks.com portfolio recommendation AAR Corp. (NYSE: AIR), which provides products and services to the aviation, aerospace, and defense industries worldwide, will be reporting earnings for their Q1/2009 fiscal...
- External links 2008-09-12
- Eli Lilly Q2 2007 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions And our first question comes from the line of James Kelly of Goldman Sachs. Please go ahead. James Kelly - Goldman Sachs Thank you and good morning. My question relates to Zyprexa and the depot formulation, and thank you for the additional data in Canada...
- Earnings calls 2007-07-24
- << Previous
- page 1 of 1
- Next >>
